Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Second biosimilar of Remicade approved in the US, but J&J not rattled
Second biosimilar of Remicade approved in the US, but J&J not rattled
Second biosimilar of Remicade approved in the US, but J&J not rattled
Submitted by
admin
on April 24, 2017 - 10:02pm
Source:
BioPharma Dive
News Tags:
Remicade
JNJ
biosimilars
Renflexis
Merck
Samsung Bioepis
Headline:
Second biosimilar of Remicade approved in the US, but J&J not rattled
Do Not Allow Advertisers to Use My Personal information
